WEKO3
インデックスリンク
アイテム
Modification of the HCMV-specific IFN-γ release test (QuantiFERON-CMV) and a novel proposal for its application
https://fmu.repo.nii.ac.jp/records/2001932
https://fmu.repo.nii.ac.jp/records/2001932f9b307e6-6db2-4081-a6dc-c5cf3a7aa214
| 名前 / ファイル | ライセンス | アクション |
|---|---|---|
FksmJMedSci_63_p64.pdf (2.2 MB)
|
|
| Item type | デフォルトアイテムタイプ（フル）fmu(1) | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 公開日 | 2017-08-28 | |||||||||||||||||||||
| タイトル | ||||||||||||||||||||||
| タイトル | Modification of the HCMV-specific IFN-γ release test (QuantiFERON-CMV) and a novel proposal for its application | |||||||||||||||||||||
| 言語 | en | |||||||||||||||||||||
| 作成者 |
Kobayashi, Takahiro
× Kobayashi, Takahiro
× Sato, Jun-Ichi
× Ikuta, Kazufumi
× Kanno, Ryoko
× Nishiyama, Kyoko
× Koshizuka, Tetsuo
× Ishioka, Ken
× Suzutani, Tatsuo
|
|||||||||||||||||||||
| 権利情報 | ||||||||||||||||||||||
| 言語 | en | |||||||||||||||||||||
| 権利情報 | © 2017 The Fukushima Society of Medical Science | |||||||||||||||||||||
| 主題 | ||||||||||||||||||||||
| 言語 | en | |||||||||||||||||||||
| 主題Scheme | Other | |||||||||||||||||||||
| 主題 | Human cytomegalovirus | |||||||||||||||||||||
| 主題 | ||||||||||||||||||||||
| 言語 | en | |||||||||||||||||||||
| 主題Scheme | Other | |||||||||||||||||||||
| 主題 | Interferon-γ | |||||||||||||||||||||
| 主題 | ||||||||||||||||||||||
| 言語 | en | |||||||||||||||||||||
| 主題Scheme | Other | |||||||||||||||||||||
| 主題 | Cellular immunity | |||||||||||||||||||||
| 内容記述 | ||||||||||||||||||||||
| 内容記述タイプ | Abstract | |||||||||||||||||||||
| 内容記述 | Human cytomegalovirus (HCMV) is universally distributed among humans without any adverse effects; however, it induces severe diseases in immunocompromised patients such as organ transplant recipients and AIDS patients. To manage these immunocompromised patients, an easy clinical examination for the monitoring of disease risk is required. In this study, we modified the interferon-γ (IFN-γ) release test (QuantiFERON®-CMV) using HCMV immediate early-1 (IE-1) or pp65 whole proteins, or UV-inactivated HCMV particles as an antigen. The response of heparinized peripheral blood from healthy volunteers to the pp65 protein showed an obvious dose-dependent sigmoid curve, although no correlation was observed between results of this assay and an ELISPOT assay. The addition of pp65 to the blood samples at a final concentration of 1×10^3 to 1×10^5 pg/ml was found to be optimum. Using this assay, we observed a significant enhancement in cellular immunity in volunteers after the daily ingestion of yogurt for 8 weeks, which suggested a novel application of the assay in addition to monitoring HCMV infection risk. IFN-γ secretion from peripheral blood cells on HCMV-antigen stimulation differed significantly between individuals; therefore, the assay could not be normalized. Nevertheless, it was found to be particularly useful for observing fluctuations in cellular immune activity on an individual level. | |||||||||||||||||||||
| 言語 | en | |||||||||||||||||||||
| 出版者 | ||||||||||||||||||||||
| 出版者 | The Fukushima Society of Medical Science | |||||||||||||||||||||
| 言語 | en | |||||||||||||||||||||
| 言語 | ||||||||||||||||||||||
| 言語 | eng | |||||||||||||||||||||
| 資源タイプ | ||||||||||||||||||||||
| 資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||||||||||||||||||
| 資源タイプ | journal article | |||||||||||||||||||||
| 出版タイプ | ||||||||||||||||||||||
| 出版タイプ | VoR | |||||||||||||||||||||
| 出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |||||||||||||||||||||
| 関連情報 | ||||||||||||||||||||||
| 関連タイプ | isIdenticalTo | |||||||||||||||||||||
| 識別子タイプ | DOI | |||||||||||||||||||||
| 関連識別子 | https://doi.org/10.5387/fms.2017-01 | |||||||||||||||||||||
| 関連情報 | ||||||||||||||||||||||
| 識別子タイプ | PMID | |||||||||||||||||||||
| 関連識別子 | 28638004 | |||||||||||||||||||||
| 関連情報 | ||||||||||||||||||||||
| 識別子タイプ | ICHUSHI | |||||||||||||||||||||
| 関連識別子 | 2018243083 | |||||||||||||||||||||
| 収録物識別子 | ||||||||||||||||||||||
| 収録物識別子タイプ | PISSN | |||||||||||||||||||||
| 収録物識別子 | 0016-2590 | |||||||||||||||||||||
| 収録物識別子 | ||||||||||||||||||||||
| 収録物識別子タイプ | EISSN | |||||||||||||||||||||
| 収録物識別子 | 2185-4610 | |||||||||||||||||||||
| 収録物識別子 | ||||||||||||||||||||||
| 収録物識別子タイプ | NCID | |||||||||||||||||||||
| 収録物識別子 | AA0065246X | |||||||||||||||||||||
| 書誌情報 |
en : Fukushima Journal of Medical Science 巻 63, 号 2, p. 64-74, 発行日 2017 |
|||||||||||||||||||||
